Article Text

PDF
Recent advances in Clostridium difficile-associated disease
  1. T Monaghan1,2,
  2. T Boswell3,
  3. Y R Mahida1,2
  1. 1
    Institute of Infection, Immunity & Inflammation, University of Nottingham and Nottingham University Hospitals NHS Trust, UK
  2. 2
    Division of Gastroenterology, University of Nottingham and Nottingham University Hospitals NHS Trust, UK
  3. 3
    Department of Clinical Microbiology, University of Nottingham and Nottingham University Hospitals NHS Trust, UK
  1. Professor Y R Mahida, Institute of Infection, Immunity & Inflammation, C Floor, West Block, Queen’s Medical Hospital Campus, Nottingham, NG7 2UH; Yash.Mahida{at}Nottingham.ac.uk

Abstract

The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.